CD52 (Alemtuzumab biosimilar) Antibody from ICHORBIO

Search, find, compare suppliers for anti-CD52 (Alemtuzumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD52 (Alemtuzumab biosimilar)
Clonemonoclonal
Host SpeciesHumanized
Reactive Specieshuman
IsotypeIgG1 kappa
FormatProtein A/G purified, low endotoxin
Size10mg
Concentration1.0 - 5.0 mg/ml
ApplicationsRUO
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSpecificity: detects human CD52. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Alemtuzumab. Alemtuzumab biosimilar is a recombinant DNA-derived humanized monoclonal antibody (Campath-1H) directed against the 21-28 kD cell surface glycoprotein, CD52, is an IgG1 kappa antibody with human variable framework and constant regions, and complementarity-determining regions from a murine (rat) monoclonal antibody. The alemtuzumab biosimilar has an approximate molecular weight of 150 kD and is produced in mammalian cell (Chinese hamster ovary) suspension culture in a medium.
Immunogenn/a
Other NamesCampath-1 antigen, Cambridge pathology 1 antigen, HE5
Gene, Accession #UniProt: P31358
Catalog #ICH4002-10mg
Price$1145
Order / More InfoCD52 (Alemtuzumab biosimilar) Antibody from ICHORBIO
Product Specific ReferencesProtection of cell therapeutics from antibody-mediated killing by CD64 overexpression: https://www.nature.com/articles/s41587-022-01540-7
ICHORBIO
ICHORBIO
ICHORBIO
Boston House, Grove Business Park
Downsview Road
Wantage OX12 9FF ENGLAND

orders@ichor.bio

https://ichor.bio

U.S. OFFICE
987 Old Eagle School Rd, Ste 709
Wayne, PA 19087
us@ichor.bio


Profile of ICHORBIO

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.